ID,Description,setSize,enrichmentScore,NES,pvalue,p.adjust,qvalues,ont,comparison
GO:0070486,leukocyte aggregation,389,0.349307227163239,1.61503308730582,0.00308641975308642,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0007159,leukocyte cell-cell adhesion,414,0.358117463747563,1.66148725842761,0.00311526479750779,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0034109,homotypic cell-cell adhesion,436,0.370685757914868,1.72281543559247,0.00313479623824451,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0071593,lymphocyte aggregation,383,0.340284975906556,1.56661930530977,0.00314465408805031,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0042110,T cell activation,382,0.341354628709363,1.5691106469132,0.00316455696202532,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0070489,T cell aggregation,382,0.341354628709363,1.5691106469132,0.00316455696202532,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0007599,hemostasis,462,0.385571780925222,1.81366264717065,0.00320512820512821,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0006091,generation of precursor metabolites and energy,394,0.329869207823649,1.54714151678651,0.0032258064516129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002768,immune response-regulating cell surface receptor signaling pathway,451,0.369675904561477,1.74312098331222,0.00324675324675325,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0006897,endocytosis,497,0.300753300505393,1.42891576991142,0.00324675324675325,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0007596,blood coagulation,457,0.393632171195459,1.84582118789303,0.00325732899022801,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002429,immune response-activating cell surface receptor signaling pathway,298,0.432094320122821,1.94699513128727,0.00326797385620915,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0043900,regulation of multi-organism process,420,0.294033975119216,1.36479959077048,0.00326797385620915,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0022407,regulation of cell-cell adhesion,320,0.341457211208072,1.55729742077827,0.00327868852459016,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0030029,actin filament-based process,498,0.320799928988659,1.52267393408858,0.00327868852459016,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0050817,coagulation,460,0.392872561646832,1.84052434670134,0.00327868852459016,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0060326,cell chemotaxis,177,0.428401161494077,1.80717613184775,0.00327868852459016,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0003012,muscle system process,276,0.304850152623721,1.37721113317064,0.00328947368421053,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0009119,ribonucleoside metabolic process,309,0.335195761288443,1.53446936630398,0.00328947368421053,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0031349,positive regulation of defense response,383,0.387608888912179,1.80013789126991,0.00328947368421053,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1903827,regulation of cellular protein localization,474,0.320173858332105,1.49711651706092,0.00328947368421053,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1903649,regulation of cytoplasmic transport,388,0.376011687725527,1.73041798629199,0.0033003300330033,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002757,immune response-activating signal transduction,433,0.411933372231619,1.91365818393097,0.0033112582781457,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0042176,regulation of protein catabolic process,356,0.326186573068649,1.50343985793086,0.0033112582781457,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051051,negative regulation of transport,366,0.338669198143954,1.55395242980583,0.0033112582781457,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002253,activation of immune response,472,0.418279899440713,1.95452587490832,0.00332225913621262,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002694,regulation of leukocyte activation,380,0.311163046346611,1.44274949546118,0.00332225913621262,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0045088,regulation of innate immune response,361,0.391057988979629,1.80064488537659,0.00332225913621262,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0090066,regulation of anatomical structure size,365,0.34644176689971,1.60065533877456,0.00332225913621262,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0009117,nucleotide metabolic process,499,0.284704857867839,1.34066498702117,0.00333333333333333,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0009161,ribonucleoside monophosphate metabolic process,227,0.363755726947212,1.61655971831078,0.00333333333333333,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0050900,leukocyte migration,282,0.416892147477856,1.85628591319595,0.00333333333333333,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1903037,regulation of leukocyte cell-cell adhesion,260,0.328661256982611,1.46566116974643,0.00333333333333333,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002218,activation of innate immune response,271,0.400898247712951,1.81324415311602,0.00334448160535117,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0009123,nucleoside monophosphate metabolic process,236,0.356113326831804,1.59024431580945,0.00334448160535117,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0009141,nucleoside triphosphate metabolic process,217,0.35824677845799,1.57782935936878,0.00334448160535117,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0009199,ribonucleoside triphosphate metabolic process,200,0.392903301109374,1.72285242266028,0.00334448160535117,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0009306,protein secretion,376,0.317709156197346,1.47814002662821,0.00334448160535117,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0032845,negative regulation of homeostatic process,145,0.390373811023555,1.61435102941099,0.00334448160535117,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0050863,regulation of T cell activation,253,0.331708273562251,1.47107950295743,0.00334448160535117,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0050865,regulation of cell activation,406,0.315308506655551,1.46401705720385,0.00334448160535117,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:2001233,regulation of apoptotic signaling pathway,333,0.326174824948209,1.48160478149703,0.00334448160535117,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0009259,ribonucleotide metabolic process,388,0.308790321807113,1.42954455108012,0.00335570469798658,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0033157,regulation of intracellular protein transport,323,0.359868312826764,1.62373035817316,0.00335570469798658,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0050708,regulation of protein secretion,312,0.326199515165268,1.4842701111584,0.00335570469798658,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0009636,response to toxic substance,205,0.36205713323234,1.5643009237381,0.00336700336700337,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051249,regulation of lymphocyte activation,332,0.314816727576458,1.44076522628881,0.00336700336700337,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1904950,negative regulation of establishment of protein localization,182,0.400211531609977,1.72071566409503,0.00336700336700337,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002521,leukocyte differentiation,395,0.300447679857773,1.39796737613045,0.00337837837837838,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0007411,axon guidance,427,0.367138401767969,1.71822293270663,0.00337837837837838,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0019932,second-messenger-mediated signaling,177,0.353621998472801,1.50012760254749,0.00337837837837838,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0043254,regulation of protein complex assembly,307,0.358925698266277,1.6186219321666,0.00337837837837838,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0050851,antigen receptor-mediated signaling pathway,194,0.404221021741337,1.73358784583724,0.00337837837837838,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051272,positive regulation of cellular component movement,323,0.336391548620663,1.52522869904178,0.00337837837837838,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0097485,neuron projection guidance,427,0.367138401767969,1.71822293270663,0.00337837837837838,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0006936,muscle contraction,223,0.321806919175997,1.41852548580364,0.00338983050847458,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0031331,positive regulation of cellular catabolic process,299,0.319725991263875,1.44564852181825,0.00338983050847458,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0032387,negative regulation of intracellular transport,131,0.416837928900827,1.72037599957172,0.00338983050847458,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0040017,positive regulation of locomotion,327,0.323524989159894,1.46300057380375,0.00338983050847458,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0050730,regulation of peptidyl-tyrosine phosphorylation,160,0.360652731938036,1.53133063392401,0.00338983050847458,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0097193,intrinsic apoptotic signaling pathway,265,0.336884933402163,1.50490335101428,0.00338983050847458,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1903651,positive regulation of cytoplasmic transport,222,0.333211850707852,1.44189061256474,0.00338983050847458,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0006887,exocytosis,293,0.360497067116262,1.61964354757828,0.00340136054421769,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0019693,ribose phosphate metabolic process,400,0.3025655760033,1.4029878506564,0.00340136054421769,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0032147,activation of protein kinase activity,385,0.301122661473327,1.39619868912624,0.00340136054421769,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0032956,regulation of actin cytoskeleton organization,229,0.358281890829816,1.58314597887036,0.00340136054421769,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0045089,positive regulation of innate immune response,312,0.387868144099599,1.76637008587214,0.00340136054421769,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0050795,regulation of behavior,171,0.365213412805817,1.54155651583635,0.00340136054421769,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1903364,positive regulation of cellular protein catabolic process,175,0.399999096721585,1.70920092899739,0.00340136054421769,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:2000147,positive regulation of cell motility,314,0.335491133958019,1.51523358382316,0.00340136054421769,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0009896,positive regulation of catabolic process,352,0.297305575340707,1.36790449431759,0.00341296928327645,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0030036,actin cytoskeleton organization,439,0.319579862279739,1.48959690012147,0.00341296928327645,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0030335,positive regulation of cell migration,307,0.3405506156173,1.5300764320421,0.00341296928327645,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0050867,positive regulation of cell activation,261,0.35179017560366,1.56869231093355,0.00341296928327645,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0060401,cytosolic calcium ion transport,98,0.456638809763603,1.80186591147524,0.00341296928327645,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1903650,negative regulation of cytoplasmic transport,106,0.43542490391919,1.73448724079785,0.00341296928327645,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:2001242,regulation of intrinsic apoptotic signaling pathway,133,0.368714179808997,1.50138786615237,0.00341296928327645,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0030595,leukocyte chemotaxis,138,0.460848872032656,1.85618056698099,0.00342465753424658,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0043410,positive regulation of MAPK cascade,478,0.328256625388011,1.54916327264608,0.00342465753424658,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0050920,regulation of chemotaxis,136,0.393701097941659,1.61556624582684,0.00342465753424658,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002220,innate immune response activating cell surface receptor signaling pathway,121,0.479975818306164,1.95590775973339,0.00343642611683849,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0009205,purine ribonucleoside triphosphate metabolic process,194,0.398267112121207,1.73487039352329,0.00343642611683849,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0016049,cell growth,368,0.312967103634759,1.44033348534465,0.00343642611683849,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0043405,regulation of MAP kinase activity,394,0.326470638153425,1.51658485042431,0.00343642611683849,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0045862,positive regulation of proteolysis,327,0.350674740107813,1.60673658057904,0.00343642611683849,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0052547,regulation of peptidase activity,289,0.316667523902217,1.42968054927605,0.00343642611683849,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1903050,regulation of proteolysis involved in cellular protein catabolic process,234,0.343674319979143,1.51193573875875,0.00343642611683849,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0001819,positive regulation of cytokine production,340,0.334626303953027,1.52504201231184,0.00344827586206897,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002250,adaptive immune response,299,0.418897401419795,1.88233752242018,0.00344827586206897,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002696,positive regulation of leukocyte activation,254,0.349900319191816,1.55681984768634,0.00344827586206897,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0034341,response to interferon-gamma,138,0.476877462118333,2.00267392231892,0.00344827586206897,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0035710,CD4-positive, alpha-beta T cell activation,58,0.506869833636709,1.87273571828405,0.00344827586206897,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051224,negative regulation of protein transport,173,0.408874921327837,1.73840118687586,0.00344827586206897,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0055082,cellular chemical homeostasis,497,0.298326088270507,1.40915032543557,0.00344827586206897,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1903530,regulation of secretion by cell,460,0.290333932471093,1.35896400018063,0.00344827586206897,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0000082,G1/S transition of mitotic cell cycle,229,0.323890224545795,1.42237818744374,0.00346020761245675,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002688,regulation of leukocyte chemotaxis,75,0.506227679573225,1.87682849081912,0.00346020761245675,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002758,innate immune response-activating signal transduction,265,0.395776113085096,1.7710801252087,0.00346020761245675,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0006163,purine nucleotide metabolic process,394,0.308044360956713,1.41814619918617,0.00346020761245675,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0009144,purine nucleoside triphosphate metabolic process,201,0.377301767340583,1.64501194727095,0.00346020761245675,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0009617,response to bacterium,400,0.34979379769222,1.61880295061973,0.00346020761245675,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0010038,response to metal ion,262,0.313662642589659,1.41012509827279,0.00346020761245675,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0034110,regulation of homotypic cell-cell adhesion,268,0.335860449667332,1.49737807656801,0.00346020761245675,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1903362,regulation of cellular protein catabolic process,251,0.348206375565673,1.53693605798959,0.00346020761245675,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002285,lymphocyte activation involved in immune response,122,0.423598239892716,1.72550496581112,0.00347222222222222,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0097553,calcium ion transmembrane import into cytosol,84,0.491206407031877,1.8961670126767,0.00347222222222222,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1902656,calcium ion import into cytosol,84,0.491206407031877,1.8961670126767,0.00347222222222222,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1903320,regulation of protein modification by small protein conjugation or removal,279,0.326568925483349,1.4848236714801,0.00347222222222222,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0001818,negative regulation of cytokine production,198,0.348577200976551,1.50628808430673,0.00348432055749129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002576,platelet degranulation,75,0.58107768595898,2.19577767327594,0.00348432055749129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,65,0.456291430042299,1.66590133869641,0.00348432055749129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0007265,Ras protein signal transduction,397,0.328156699368089,1.54391508720682,0.00348432055749129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0009126,purine nucleoside monophosphate metabolic process,217,0.377172381495876,1.66271974713906,0.00348432055749129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0009167,purine ribonucleoside monophosphate metabolic process,217,0.377172381495876,1.66271974713906,0.00348432055749129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0032970,regulation of actin filament-based process,254,0.363725367755884,1.61646718788646,0.00348432055749129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051090,regulation of sequence-specific DNA binding transcription factor activity,301,0.313050040657283,1.42120282621943,0.00348432055749129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051924,regulation of calcium ion transport,148,0.403633655866879,1.68588863095959,0.00348432055749129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0060402,calcium ion transport into cytosol,97,0.469065999061424,1.84322735569749,0.00348432055749129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0071621,granulocyte chemotaxis,76,0.469828770965296,1.74239836399031,0.00348432055749129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1903533,regulation of protein targeting,256,0.362278058158481,1.60863910215792,0.00348432055749129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0009150,purine ribonucleotide metabolic process,374,0.31601420094963,1.45314252227271,0.0034965034965035,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0019882,antigen processing and presentation,219,0.380410050490321,1.67017820226432,0.0034965034965035,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0045785,positive regulation of cell adhesion,305,0.356770279275917,1.60574989898717,0.0034965034965035,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0046034,ATP metabolic process,181,0.413831053487078,1.78950437847704,0.0034965034965035,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1900180,regulation of protein localization to nucleus,181,0.361295277393236,1.53366537082452,0.0034965034965035,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0001836,release of cytochrome c from mitochondria,54,0.439555485685888,1.56259273578337,0.00350877192982456,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002223,stimulatory C-type lectin receptor signaling pathway,118,0.457402953078984,1.85018979489171,0.00350877192982456,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0007015,actin filament organization,261,0.374319358780009,1.67264474673741,0.00350877192982456,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0019724,B cell mediated immunity,92,0.461467109850239,1.78233074258808,0.00350877192982456,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0038093,Fc receptor signaling pathway,320,0.372455789087476,1.70991931132222,0.00350877192982456,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1903052,positive regulation of proteolysis involved in cellular protein catabolic process,163,0.394679035467125,1.66398370914813,0.00350877192982456,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,197,0.431110809840597,1.83707925972167,0.00352112676056338,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002683,negative regulation of immune system process,306,0.333426843188236,1.50714987822338,0.00352112676056338,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002685,regulation of leukocyte migration,116,0.472956431834391,1.88204565080501,0.00352112676056338,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002821,positive regulation of adaptive immune response,69,0.46025194724356,1.68991164669508,0.00352112676056338,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0009615,response to virus,345,0.361964969679831,1.64606919257132,0.00352112676056338,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0010959,regulation of metal ion transport,230,0.335331553472747,1.47319479904793,0.00352112676056338,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0032535,regulation of cellular component size,280,0.33997080181524,1.51503553692441,0.00352112676056338,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0048002,antigen processing and presentation of peptide antigen,180,0.40163329396914,1.7267040556268,0.00352112676056338,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0052548,regulation of endopeptidase activity,272,0.321478225935182,1.43495585760243,0.00352112676056338,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0070509,calcium ion import,113,0.481617025194087,1.92617106657812,0.00352112676056338,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0098542,defense response to other organism,409,0.38161676426022,1.76518525791899,0.00352112676056338,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0098754,detoxification,70,0.523449786532441,1.93292449559058,0.00352112676056338,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1903706,regulation of hemopoiesis,273,0.337984683078605,1.51427790441819,0.00352112676056338,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002706,regulation of lymphocyte mediated immunity,101,0.455112354422664,1.79433317554391,0.00353356890459364,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0038179,neurotrophin signaling pathway,347,0.344421542139744,1.59222571900425,0.00353356890459364,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0042035,regulation of cytokine biosynthetic process,86,0.420638993928251,1.62055095241285,0.00353356890459364,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0043434,response to peptide hormone,491,0.311918085719486,1.47543261889759,0.00353356890459364,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051251,positive regulation of lymphocyte activation,231,0.359234977271386,1.58409575754025,0.00353356890459364,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0090087,regulation of peptide transport,204,0.349356393847367,1.52044057533697,0.00353356890459364,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1990266,neutrophil migration,73,0.495860846106108,1.82592812155842,0.00353356890459364,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0030003,cellular cation homeostasis,389,0.313778228276905,1.45661527922392,0.00354609929078014,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0030168,platelet activation,220,0.503638250340048,2.20476931427264,0.00354609929078014,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0031396,regulation of protein ubiquitination,259,0.354623780783693,1.59689948595264,0.00354609929078014,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0034612,response to tumor necrosis factor,234,0.453626717829275,2.01451984971555,0.00354609929078014,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0048011,neurotrophin TRK receptor signaling pathway,345,0.340502175624719,1.57195491492351,0.00354609929078014,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1902105,regulation of leukocyte differentiation,202,0.38081892780728,1.66551202907329,0.00354609929078014,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002478,antigen processing and presentation of exogenous peptide antigen,163,0.421650264051559,1.79050540692049,0.00355871886120996,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0030593,neutrophil chemotaxis,68,0.496166815511244,1.79079985588659,0.00355871886120996,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0032868,response to insulin,384,0.325155423329501,1.52039743693455,0.00355871886120996,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0043367,CD4-positive, alpha-beta T cell differentiation,52,0.503684896265938,1.81190719510836,0.00355871886120996,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0050852,T cell receptor signaling pathway,160,0.436896253114334,1.82275634773596,0.00355871886120996,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0090317,negative regulation of intracellular protein transport,93,0.426491057869819,1.68053376629263,0.00355871886120996,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1990748,cellular detoxification,67,0.526845698711673,1.9281813633761,0.00355871886120996,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002573,myeloid leukocyte differentiation,165,0.345949730375604,1.45794180101332,0.00357142857142857,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0009164,nucleoside catabolic process,31,0.570407642711691,1.80813839872083,0.00357142857142857,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0050663,cytokine secretion,144,0.39718216424081,1.64922487408482,0.00357142857142857,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0071496,cellular response to external stimulus,220,0.341654256488364,1.4911647329926,0.00357142857142857,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0072593,reactive oxygen species metabolic process,200,0.372942671926842,1.62942936755051,0.00357142857142857,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0098869,cellular oxidant detoxification,64,0.536767104102095,1.9452453484627,0.00357142857142857,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1903321,negative regulation of protein modification by small protein conjugation or removal,151,0.391623034387859,1.67368148861889,0.00357142857142857,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:2001236,regulation of extrinsic apoptotic signaling pathway,132,0.38582204976983,1.57303253184905,0.00357142857142857,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002687,positive regulation of leukocyte migration,87,0.548592347197745,2.08792043182169,0.003584229390681,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002690,positive regulation of leukocyte chemotaxis,63,0.53743114986148,1.93090792615046,0.003584229390681,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0007204,positive regulation of cytosolic calcium ion concentration,176,0.387689832932472,1.64143261162284,0.003584229390681,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0030111,regulation of Wnt signaling pathway,245,0.361077151912823,1.59995604007764,0.003584229390681,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0032103,positive regulation of response to external stimulus,226,0.391757583536416,1.72098674717158,0.003584229390681,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0034764,positive regulation of transmembrane transport,87,0.408505707590518,1.56924108431892,0.003584229390681,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0045732,positive regulation of protein catabolic process,239,0.353288968974138,1.55967582671675,0.003584229390681,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0050870,positive regulation of T cell activation,180,0.391974100185808,1.67005115753554,0.003584229390681,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051348,negative regulation of transferase activity,305,0.312471044795693,1.43376872918062,0.003584229390681,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0098771,inorganic ion homeostasis,452,0.319284582613842,1.496070787633,0.003584229390681,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1903039,positive regulation of leukocyte cell-cell adhesion,184,0.392539608211751,1.67685275710603,0.003584229390681,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1903322,positive regulation of protein modification by small protein conjugation or removal,181,0.382082568952937,1.64593237949524,0.003584229390681,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0000041,transition metal ion transport,90,0.445789488096962,1.73306906948143,0.00359712230215827,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002449,lymphocyte mediated immunity,189,0.449623223239786,1.90033083397005,0.00359712230215827,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0006873,cellular ion homeostasis,398,0.316314026133919,1.46498044312128,0.00359712230215827,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0006909,phagocytosis,188,0.417714917175518,1.81657834307276,0.00359712230215827,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0034112,positive regulation of homotypic cell-cell adhesion,183,0.393368490861977,1.67701790479737,0.00359712230215827,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0038127,ERBB signaling pathway,315,0.295859736213137,1.35076067325122,0.00359712230215827,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0042107,cytokine metabolic process,98,0.407498539745463,1.59409015641444,0.00359712230215827,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051282,regulation of sequestering of calcium ion,83,0.499920216276261,1.91675581688925,0.00359712230215827,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051928,positive regulation of calcium ion transport,73,0.465654428841168,1.76889756458764,0.00359712230215827,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0060333,interferon-gamma-mediated signaling pathway,83,0.490733698217075,1.89085968246551,0.00359712230215827,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0060828,regulation of canonical Wnt signaling pathway,192,0.376603931903146,1.62174207962457,0.00359712230215827,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0000209,protein polyubiquitination,214,0.320391390791733,1.39421480047611,0.0036101083032491,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002237,response to molecule of bacterial origin,284,0.343568611572223,1.53937874901788,0.0036101083032491,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002431,Fc receptor mediated stimulatory signaling pathway,78,0.519129258495739,1.95141284598085,0.0036101083032491,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,102,0.52481437149655,2.10369465332758,0.0036101083032491,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0016064,immunoglobulin mediated immune response,89,0.455449100722234,1.7321146047011,0.0036101083032491,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0030198,extracellular matrix organization,247,0.324707014873786,1.42721220647688,0.0036101083032491,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0031398,positive regulation of protein ubiquitination,168,0.401497138497182,1.7113549036798,0.0036101083032491,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0042743,hydrogen peroxide metabolic process,35,0.583955398088291,1.91692780406059,0.0036101083032491,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0044089,positive regulation of cellular component biogenesis,320,0.331872400593325,1.50126652688397,0.0036101083032491,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0050727,regulation of inflammatory response,218,0.415969890231247,1.82182436444631,0.0036101083032491,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051209,release of sequestered calcium ion into cytosol,82,0.500975121125139,1.91476135935357,0.0036101083032491,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051283,negative regulation of sequestering of calcium ion,82,0.500975121125139,1.91476135935357,0.0036101083032491,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051340,regulation of ligase activity,129,0.398414100474958,1.67453371526286,0.0036101083032491,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0070555,response to interleukin-1,92,0.461179091770658,1.79729819540736,0.0036101083032491,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0071375,cellular response to peptide hormone stimulus,416,0.322719670868592,1.50820873701223,0.0036101083032491,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:2000021,regulation of ion homeostasis,141,0.411169269160725,1.69693263190726,0.0036101083032491,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0001906,cell killing,82,0.506442092751316,1.9166747511473,0.0036231884057971,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0001909,leukocyte mediated cytotoxicity,72,0.532809417978771,1.98984127726965,0.0036231884057971,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002443,leukocyte mediated immunity,251,0.416523290094032,1.83090785635637,0.0036231884057971,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0006818,hydrogen transport,124,0.411644784464968,1.69805103065601,0.0036231884057971,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0022409,positive regulation of cell-cell adhesion,204,0.386241333899644,1.66263649896094,0.0036231884057971,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0042089,cytokine biosynthetic process,96,0.405980621881797,1.58043855243708,0.0036231884057971,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0042742,defense response to bacterium,138,0.424634616075326,1.76032098282282,0.0036231884057971,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051208,sequestering of calcium ion,86,0.495775032448692,1.9136843957217,0.0036231884057971,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051238,sequestering of metal ion,96,0.497990544666378,1.94131138333838,0.0036231884057971,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0071346,cellular response to interferon-gamma,117,0.468240339862539,1.89168607811605,0.0036231884057971,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1903034,regulation of response to wounding,304,0.371407042498144,1.68332810555452,0.0036231884057971,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002699,positive regulation of immune effector process,137,0.423987426479907,1.72696683977612,0.00363636363636364,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0031397,negative regulation of protein ubiquitination,143,0.428019177409712,1.81192892816064,0.00363636363636364,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0032640,tumor necrosis factor production,94,0.450441895741837,1.76603318982084,0.00363636363636364,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0050707,regulation of cytokine secretion,126,0.40105100690928,1.63393280593809,0.00363636363636364,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051235,maintenance of location,240,0.353375892115543,1.56070746573345,0.00363636363636364,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051258,protein polymerization,196,0.389107189756476,1.67002857616875,0.00363636363636364,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0072331,signal transduction by p53 class mediator,155,0.422760572977224,1.78277326168402,0.00363636363636364,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002440,production of molecular mediator of immune response,134,0.408338307819473,1.68928697248803,0.00364963503649635,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002819,regulation of adaptive immune response,112,0.44685346098372,1.7729838792671,0.00364963503649635,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,102,0.438563114593871,1.72322808799147,0.00364963503649635,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0008064,regulation of actin polymerization or depolymerization,136,0.423361807046418,1.72535722315765,0.00364963503649635,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0015992,proton transport,122,0.424468679024597,1.73944395789862,0.00364963503649635,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0033238,regulation of cellular amine metabolic process,75,0.505506469486554,1.9126065643037,0.00364963503649635,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0034340,response to type I interferon,72,0.542416950173316,2.01655624426101,0.00364963503649635,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0044344,cellular response to fibroblast growth factor stimulus,279,0.342362338568363,1.54567901980316,0.00364963503649635,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0060337,type I interferon signaling pathway,68,0.55829373264222,2.05337110706134,0.00364963503649635,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0071357,cellular response to type I interferon,68,0.55829373264222,2.05337110706134,0.00364963503649635,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0071774,response to fibroblast growth factor,283,0.340494835219939,1.54097170111051,0.00364963503649635,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0007050,cell cycle arrest,227,0.338144761521894,1.48560287302771,0.00366300366300366,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0019884,antigen processing and presentation of exogenous antigen,170,0.387790803344682,1.64268610795653,0.00366300366300366,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0032869,cellular response to insulin stimulus,345,0.326942867488658,1.50533669066564,0.00366300366300366,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0038094,Fc-gamma receptor signaling pathway,76,0.531323354225747,2.00500099328502,0.00366300366300366,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051438,regulation of ubiquitin-protein transferase activity,129,0.379160792494954,1.58992521390333,0.00366300366300366,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0055065,metal ion homeostasis,406,0.315593874201073,1.46325950999439,0.00366300366300366,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0060218,hematopoietic stem cell differentiation,14,0.693295934058552,1.81141132474451,0.00366300366300366,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0071706,tumor necrosis factor superfamily cytokine production,98,0.472294300562268,1.86692549163426,0.00366300366300366,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1902107,positive regulation of leukocyte differentiation,117,0.38358621803964,1.56845350672756,0.00366300366300366,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002221,pattern recognition receptor signaling pathway,176,0.351927969603671,1.48130168125268,0.00367647058823529,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0006521,regulation of cellular amino acid metabolic process,60,0.593231919900242,2.15495496220525,0.00367647058823529,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0008154,actin polymerization or depolymerization,156,0.394846885581899,1.64329074101264,0.00367647058823529,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0030193,regulation of blood coagulation,63,0.421165942315711,1.55907626449621,0.00367647058823529,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0032680,regulation of tumor necrosis factor production,93,0.456801279543909,1.78507239876333,0.00367647058823529,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0046823,negative regulation of nucleocytoplasmic transport,71,0.407562313663402,1.51273371834496,0.00367647058823529,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0055080,cation homeostasis,443,0.318436609360822,1.48664387073642,0.00367647058823529,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0071347,cellular response to interleukin-1,68,0.438222958887167,1.60221787685016,0.00367647058823529,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0090280,positive regulation of calcium ion import,34,0.519972159255536,1.69380732307146,0.00367647058823529,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1900046,regulation of hemostasis,63,0.421165942315711,1.55907626449621,0.00367647058823529,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:2000060,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,85,0.51837186276854,2.03371912818063,0.00367647058823529,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002718,regulation of cytokine production involved in immune response,52,0.519317813680636,1.83863262525723,0.003690036900369,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0030330,DNA damage response, signal transduction by p53 class mediator,104,0.480145060973449,1.93265316328933,0.003690036900369,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0032271,regulation of protein polymerization,151,0.399168214240691,1.65045011995487,0.003690036900369,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0042787,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,188,0.343228447741698,1.47499857876636,0.003690036900369,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0050848,regulation of calcium-mediated signaling,64,0.482647479493569,1.75307523353349,0.003690036900369,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051437,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,73,0.522777467828868,2.00694840852241,0.003690036900369,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051607,defense response to virus,275,0.365242053462725,1.63248092544405,0.003690036900369,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051926,negative regulation of calcium ion transport,32,0.550524214565007,1.74308649596605,0.003690036900369,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0071158,positive regulation of cell cycle arrest,84,0.567694652644101,2.23042853318204,0.003690036900369,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0071622,regulation of granulocyte chemotaxis,31,0.566098198496043,1.77165154227122,0.003690036900369,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0072507,divalent inorganic cation homeostasis,289,0.32801457810969,1.46464376389163,0.003690036900369,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002286,T cell activation involved in immune response,67,0.52669588631547,1.99087153003669,0.0037037037037037,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0010043,response to zinc ion,37,0.552773112605092,1.82181852107906,0.0037037037037037,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0030177,positive regulation of Wnt signaling pathway,141,0.385848884092739,1.57337907283598,0.0037037037037037,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0042590,antigen processing and presentation of exogenous peptide antigen via MHC class I,78,0.615472143367345,2.36162755749096,0.0037037037037037,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0045454,cell redox homeostasis,79,0.414582732118055,1.57789980376772,0.0037037037037037,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0050801,ion homeostasis,494,0.314301178386361,1.47891808262306,0.0037037037037037,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,96,0.469924369823533,1.84486873296918,0.0037037037037037,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0000186,activation of MAPKK activity,197,0.392796910622598,1.70249563208144,0.00371747211895911,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002263,cell activation involved in immune response,176,0.402045455664972,1.71075246487928,0.00371747211895911,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002433,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,72,0.516219406248554,1.90991089358312,0.00371747211895911,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0008286,insulin receptor signaling pathway,291,0.347025478289372,1.5685863798617,0.00371747211895911,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0030832,regulation of actin filament length,137,0.422922191485723,1.71915850304822,0.00371747211895911,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0031145,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,85,0.514531724260033,2.00873303910998,0.00371747211895911,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0032496,response to lipopolysaccharide,273,0.350556356749951,1.56093518855392,0.00371747211895911,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0038096,Fc-gamma receptor signaling pathway involved in phagocytosis,72,0.516219406248554,1.90991089358312,0.00371747211895911,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,220,0.393997676315285,1.73584573875165,0.00371747211895911,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051352,negative regulation of ligase activity,98,0.459799012723824,1.85577324249875,0.00371747211895911,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051439,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,98,0.43558530034965,1.76475722754263,0.00371747211895911,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051495,positive regulation of cytoskeleton organization,160,0.398071728774855,1.65338419694076,0.00371747211895911,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0070527,platelet aggregation,45,0.5926878109765,1.99840161517296,0.00371747211895911,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0072431,signal transduction involved in mitotic G1 DNA damage checkpoint,64,0.587322030895329,2.17759144436648,0.00371747211895911,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1902400,intracellular signal transduction involved in G1 DNA damage checkpoint,64,0.587322030895329,2.17759144436648,0.00371747211895911,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0006801,superoxide metabolic process,42,0.480448209328432,1.64784383019887,0.00373134328358209,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0006875,cellular metal ion homeostasis,359,0.306710845052715,1.40479407884297,0.00373134328358209,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0043488,regulation of mRNA stability,127,0.392339835974883,1.62098696516958,0.00373134328358209,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0048010,vascular endothelial growth factor receptor signaling pathway,254,0.444196691775722,1.97416629060785,0.00373134328358209,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0060759,regulation of response to cytokine stimulus,124,0.421173264665838,1.70404739841295,0.00373134328358209,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:2000058,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,94,0.475169384618481,1.87490156479851,0.00373134328358209,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand,37,0.570611231536438,1.86522641620801,0.00373134328358209,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002287,alpha-beta T cell activation involved in immune response,43,0.577375795378727,2.01045655170738,0.00374531835205993,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002293,alpha-beta T cell differentiation involved in immune response,43,0.577375795378727,2.01045655170738,0.00374531835205993,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002294,CD4-positive, alpha-beta T cell differentiation involved in immune response,43,0.577375795378727,2.01045655170738,0.00374531835205993,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002479,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,74,0.626387424957612,2.37780916665244,0.00374531835205993,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0008543,fibroblast growth factor receptor signaling pathway,266,0.322838915122719,1.44696716919073,0.00374531835205993,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0033209,tumor necrosis factor-mediated signaling pathway,156,0.488428039452754,2.058520475962,0.00374531835205993,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0048013,ephrin receptor signaling pathway,80,0.513144489817348,1.93540677132246,0.00374531835205993,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051091,positive regulation of sequence-specific DNA binding transcription factor activity,184,0.366229197413658,1.58023298973685,0.00374531835205993,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051351,positive regulation of ligase activity,97,0.435316839171921,1.71925319824784,0.00374531835205993,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0060314,regulation of ryanodine-sensitive calcium-release channel activity,20,0.678990005806691,1.97784488436777,0.00374531835205993,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0061025,membrane fusion,142,0.3640317257206,1.49290824055572,0.00374531835205993,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002292,T cell differentiation involved in immune response,48,0.539650629572038,1.90123101707579,0.0037593984962406,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002703,regulation of leukocyte mediated immunity,137,0.451860045804112,1.83989435250724,0.0037593984962406,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0046632,alpha-beta T cell differentiation,74,0.466832021946695,1.7669851685449,0.0037593984962406,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0048520,positive regulation of behavior,108,0.395038218423875,1.54958658743947,0.0037593984962406,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051444,negative regulation of ubiquitin-protein transferase activity,97,0.455847804842824,1.83500735796058,0.0037593984962406,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0071156,regulation of cell cycle arrest,103,0.477799494295365,1.93683578978626,0.0037593984962406,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0072395,signal transduction involved in cell cycle checkpoint,68,0.564768265528575,2.10951429550498,0.0037593984962406,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0072401,signal transduction involved in DNA integrity checkpoint,68,0.564768265528575,2.10951429550498,0.0037593984962406,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0072422,signal transduction involved in DNA damage checkpoint,68,0.564768265528575,2.10951429550498,0.0037593984962406,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002366,leukocyte activation involved in immune response,175,0.402325956677717,1.70918150368785,0.00377358490566038,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002761,regulation of myeloid leukocyte differentiation,91,0.419156480288139,1.62485932766581,0.00377358490566038,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0006959,humoral immune response,121,0.450866372239282,1.8271653148726,0.00377358490566038,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0007229,integrin-mediated signaling pathway,77,0.452382949985393,1.71879209655597,0.00377358490566038,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0048525,negative regulation of viral process,81,0.444011368466779,1.7019105009159,0.00377358490566038,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0050921,positive regulation of chemotaxis,95,0.444630771862804,1.71192797000947,0.00377358490566038,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051279,regulation of release of sequestered calcium ion into cytosol,54,0.562701351838788,2.02817035663966,0.00377358490566038,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0060306,regulation of membrane repolarization,20,-0.611463759736986,-1.79462003634617,0.00377358490566038,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0071356,cellular response to tumor necrosis factor,214,0.484617614361441,2.09836902514858,0.00377358490566038,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0072503,cellular divalent inorganic cation homeostasis,276,0.323760862252571,1.44012117786902,0.00377358490566038,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1904029,regulation of cyclin-dependent protein kinase activity,119,0.448460590038058,1.83111268565828,0.00377358490566038,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,78,0.513398140359913,1.95317012515043,0.00378787878787879,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0001912,positive regulation of leukocyte mediated cytotoxicity,29,0.56497302350115,1.75158110544269,0.00378787878787879,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0006595,polyamine metabolic process,75,0.507814010752342,1.92322315134269,0.00378787878787879,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0006977,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,63,0.590882299762213,2.18792461074645,0.00378787878787879,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0030833,regulation of actin filament polymerization,120,0.414513911316153,1.65491205577212,0.00378787878787879,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0038061,NIK/NF-kappaB signaling,101,0.468567760060903,1.89072623412918,0.00378787878787879,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0042475,odontogenesis of dentin-containing tooth,54,0.478024212923347,1.7139009476834,0.00378787878787879,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0043487,regulation of RNA stability,129,0.385801026286725,1.59471478277835,0.00378787878787879,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051436,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,90,0.449559469963664,1.78080255295693,0.00378787878787879,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0072413,signal transduction involved in mitotic cell cycle checkpoint,66,0.569642506758341,2.12051488665226,0.00378787878787879,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1901653,cellular response to peptide,431,0.318166175526993,1.48123503606037,0.00378787878787879,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1902402,signal transduction involved in mitotic DNA damage checkpoint,66,0.569642506758341,2.12051488665226,0.00378787878787879,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1902403,signal transduction involved in mitotic DNA integrity checkpoint,66,0.569642506758341,2.12051488665226,0.00378787878787879,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0001910,regulation of leukocyte mediated cytotoxicity,44,0.539145357586556,1.80885767207224,0.00380228136882129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0001959,regulation of cytokine-mediated signaling pathway,118,0.433011481065483,1.73276689684133,0.00380228136882129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002274,myeloid leukocyte activation,138,0.398652221702058,1.62088248115228,0.00380228136882129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002697,regulation of immune effector process,358,0.370903702568283,1.70275172248259,0.00380228136882129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0015833,peptide transport,248,0.331984119857338,1.46110434578082,0.00380228136882129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0030041,actin filament polymerization,134,0.401543558112822,1.62764750757791,0.00380228136882129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0032459,regulation of protein oligomerization,26,0.580440645471613,1.74000267763949,0.00380228136882129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0042093,T-helper cell differentiation,41,0.586442019025668,2.01280523255042,0.00380228136882129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0050777,negative regulation of immune response,98,0.413605302759658,1.63403953529214,0.00380228136882129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0090090,negative regulation of canonical Wnt signaling pathway,128,0.443514534736619,1.79899075715655,0.00380228136882129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1903901,negative regulation of viral life cycle,79,0.436675714993309,1.65689852625493,0.00380228136882129,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0042770,signal transduction in response to DNA damage,120,0.484597695521912,1.96241467289907,0.00381679389312977,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051092,positive regulation of NF-kappaB transcription factor activity,112,0.417959798297831,1.70856105919452,0.00381679389312977,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002675,positive regulation of acute inflammatory response,22,0.612652591706566,1.77920377516306,0.00383141762452107,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0006007,glucose catabolic process,28,0.592721897088548,1.83313769324508,0.00383141762452107,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0010881,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,17,0.6210776231309,1.7533942435143,0.00383141762452107,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0050729,positive regulation of inflammatory response,83,0.489921092623335,1.86603180828043,0.00383141762452107,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0090263,positive regulation of canonical Wnt signaling pathway,114,0.404025277959575,1.61267455402977,0.00383141762452107,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0090322,regulation of superoxide metabolic process,18,0.61696900245317,1.70712432303232,0.00383141762452107,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002700,regulation of production of molecular mediator of immune response,88,0.47983729862598,1.83848502789921,0.00384615384615385,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002707,negative regulation of lymphocyte mediated immunity,29,0.624553755511604,1.9758148291849,0.00384615384615385,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0010522,regulation of calcium ion transport into cytosol,66,0.541643403722683,1.98626971604447,0.00384615384615385,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0030178,negative regulation of Wnt signaling pathway,151,0.445026736742412,1.85791941286158,0.00384615384615385,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0030316,osteoclast differentiation,72,0.443509905597116,1.62323021258035,0.00384615384615385,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0031571,mitotic G1 DNA damage checkpoint,73,0.521103716767726,1.95800924187294,0.00384615384615385,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0042267,natural killer cell mediated cytotoxicity,46,0.53681429457778,1.8523392244302,0.00384615384615385,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0042886,amide transport,265,0.315064562385496,1.39299044719204,0.00384615384615385,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0044773,mitotic DNA damage checkpoint,99,0.420604015761662,1.64901773715297,0.00384615384615385,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0050427,3'-phosphoadenosine 5'-phosphosulfate metabolic process,15,0.68024791479757,1.82160137971025,0.00384615384615385,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1902624,positive regulation of neutrophil migration,24,0.602845989088284,1.74556230391658,0.00384615384615385,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0006826,iron ion transport,50,0.47502721792327,1.66721764220419,0.00386100386100386,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0007249,I-kappaB kinase/NF-kappaB signaling,246,0.385232602904625,1.71200460213644,0.00386100386100386,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0010665,regulation of cardiac muscle cell apoptotic process,15,0.681336952097012,1.72687537681548,0.00386100386100386,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0044819,mitotic G1/S transition checkpoint,74,0.518716891257479,1.94755466480127,0.00386100386100386,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0045071,negative regulation of viral genome replication,46,0.550295792085168,1.89916965686728,0.00386100386100386,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0051443,positive regulation of ubiquitin-protein transferase activity,92,0.4634049046022,1.81179997115984,0.00386100386100386,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0072676,lymphocyte migration,54,0.475462156661888,1.65834902981203,0.00386100386100386,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0019674,NAD metabolic process,51,0.465199941594787,1.62779788053079,0.00387596899224806,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0031146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,21,0.642482879238558,1.80294827429524,0.00387596899224806,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0042088,T-helper 1 type immune response,34,0.55441110957446,1.76071057856107,0.00387596899224806,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0090279,regulation of calcium ion import,70,0.525551886644344,1.9588087865083,0.00387596899224806,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002526,acute inflammatory response,104,0.453480532582199,1.79903033357018,0.00389105058365759,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0010880,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,20,0.646350877163921,1.87964864877058,0.00389105058365759,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0072539,T-helper 17 cell differentiation,12,0.7899294497783,2.00482801231597,0.00389105058365759,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0006364,rRNA processing,150,-0.342742135919961,-1.4692976822964,0.00390625,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0045599,negative regulation of fat cell differentiation,31,0.585558073690299,1.81799287954377,0.00390625,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1903409,reactive oxygen species biosynthetic process,75,0.43869135974858,1.63562314151239,0.00390625,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002820,negative regulation of adaptive immune response,29,0.556737334566826,1.76562186845089,0.00392156862745098,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,169,0.393626671578159,1.6763115459579,0.00392156862745098,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1903036,positive regulation of response to wounding,119,0.438198568598645,1.73950016418124,0.00392156862745098,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,55,0.523943770362884,1.88642807767737,0.00392156862745098,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002920,regulation of humoral immune response,36,0.556536276734884,1.77910945028015,0.00393700787401575,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0044783,G1 DNA damage checkpoint,74,0.516680635695317,1.92804389174083,0.00393700787401575,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0072538,T-helper 17 type immune response,13,0.754597721077574,1.93618327081033,0.00393700787401575,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:2000045,regulation of G1/S transition of mitotic cell cycle,134,0.388227575345414,1.58380339773837,0.00393700787401575,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0006119,oxidative phosphorylation,76,0.445005279418719,1.67740248310535,0.00396825396825397,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0032760,positive regulation of tumor necrosis factor production,53,0.514250182759327,1.8401825628933,0.00396825396825397,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:1901099,negative regulation of signal transduction in absence of ligand,24,0.631307037906132,1.87547606311097,0.00396825396825397,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,24,0.631307037906132,1.87547606311097,0.00396825396825397,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002673,regulation of acute inflammatory response,52,0.533043157977841,1.85682191147007,0.00398406374501992,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002693,positive regulation of cellular extravasation,11,0.76857960259257,1.84727878985048,0.00398406374501992,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0032677,regulation of interleukin-8 production,52,0.508947238749793,1.74614747787528,0.00398406374501992,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0043370,regulation of CD4-positive, alpha-beta T cell differentiation,31,0.531658999952593,1.69095947469891,0.00398406374501992,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0045064,T-helper 2 cell differentiation,14,0.725624001431966,1.89771247575822,0.00398406374501992,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0046475,glycerophospholipid catabolic process,12,0.727139491279179,1.80064170859639,0.00398406374501992,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0010658,striated muscle cell apoptotic process,21,0.629543443930912,1.73145701297972,0.004,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0032637,interleukin-8 production,56,0.480316905019275,1.68346106748083,0.004,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0042254,ribosome biogenesis,224,-0.336487192992225,-1.50913807972809,0.004,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0042345,regulation of NF-kappaB import into nucleus,44,0.558901033253303,1.90459921661264,0.004,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0042348,NF-kappaB import into nucleus,44,0.558901033253303,1.90459921661264,0.004,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0070098,chemokine-mediated signaling pathway,54,0.550739305043437,1.93862093895829,0.00401606425702811,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:2001057,reactive nitrogen species metabolic process,70,0.476443139948138,1.77522859075063,0.00401606425702811,0.0473818350324374,0.0389716761783978,BP,mono-sp-vs-rr
GO:0002704,negative regulation of leukocyte mediated immunity,38,0.57258383960121,1.91360549405425,0.00404858299595142,0.0475029036004646,0.0390712553742079,BP,mono-sp-vs-rr
GO:0002825,regulation of T-helper 1 type immune response,17,0.680653323569369,1.85521852307911,0.00404858299595142,0.0475029036004646,0.0390712553742079,BP,mono-sp-vs-rr
GO:0002698,negative regulation of immune effector process,84,0.422818640004325,1.64228981086226,0.0040650406504065,0.0475029036004646,0.0390712553742079,BP,mono-sp-vs-rr
GO:0021532,neural tube patterning,25,-0.589620890003918,-1.85003174073107,0.0040650406504065,0.0475029036004646,0.0390712553742079,BP,mono-sp-vs-rr
GO:0046209,nitric oxide metabolic process,66,0.484461560732418,1.78699489190281,0.00408163265306122,0.0475834989577779,0.0391375452543813,BP,mono-sp-vs-rr
GO:0045670,regulation of osteoclast differentiation,50,0.472867124144961,1.612670093484,0.00409836065573771,0.0476652940719447,0.0392048219375258,BP,mono-sp-vs-rr
GO:0034470,ncRNA processing,318,-0.299961037048068,-1.39545301650308,0.00411522633744856,0.0476689976689977,0.0392078681552366,BP,mono-sp-vs-rr
GO:0006734,NADH metabolic process,34,0.579627829151505,1.81593457036281,0.00416666666666667,0.0476689976689977,0.0392078681552366,BP,mono-sp-vs-rr
GO:0006735,NADH regeneration,24,0.629906934035039,1.85970223247897,0.00416666666666667,0.0476689976689977,0.0392078681552366,BP,mono-sp-vs-rr
GO:0061615,glycolytic process through fructose-6-phosphate,24,0.629906934035039,1.85970223247897,0.00416666666666667,0.0476689976689977,0.0392078681552366,BP,mono-sp-vs-rr
GO:0061620,glycolytic process through glucose-6-phosphate,24,0.629906934035039,1.85970223247897,0.00416666666666667,0.0476689976689977,0.0392078681552366,BP,mono-sp-vs-rr
GO:0061621,canonical glycolysis,24,0.629906934035039,1.85970223247897,0.00416666666666667,0.0476689976689977,0.0392078681552366,BP,mono-sp-vs-rr
GO:0061718,glucose catabolic process to pyruvate,24,0.629906934035039,1.85970223247897,0.00416666666666667,0.0476689976689977,0.0392078681552366,BP,mono-sp-vs-rr
GO:0001947,heart looping,34,-0.528228953786614,-1.7542767525418,0.00418410041841004,0.0477571275664104,0.0392803552132252,BP,mono-sp-vs-rr
GO:0032757,positive regulation of interleukin-8 production,38,0.589530688930782,1.9228324373867,0.00420168067226891,0.047846516796974,0.0393538780758365,BP,mono-sp-vs-rr
GO:0003143,embryonic heart tube morphogenesis,39,-0.505615288472472,-1.74028483879819,0.00421940928270042,0.0479371776840131,0.0394284468790354,BP,mono-sp-vs-rr
GO:0045494,photoreceptor cell maintenance,26,-0.605797054147581,-1.81328475908345,0.00427350427350427,0.0484396281163025,0.0398417135988547,BP,mono-sp-vs-rr
GO:0010501,RNA secondary structure unwinding,41,-0.584859373891885,-1.98437056881113,0.00436681222707424,0.0492696882999548,0.0405244401471983,BP,mono-sp-vs-rr
GO:0022613,ribonucleoprotein complex biogenesis,361,-0.320772713065189,-1.51164765373772,0.00436681222707424,0.0492696882999548,0.0405244401471983,BP,mono-sp-vs-rr
GO:0009855,determination of bilateral symmetry,81,-0.454660264935619,-1.7880575865506,0.0043859649122807,0.0493722839208112,0.0406088252983981,BP,mono-sp-vs-rr
GO:0015931,nucleobase-containing compound transport,179,-0.340686026354492,-1.49116206044691,0.00440528634361234,0.0494763052046896,0.0406943830609498,BP,mono-sp-vs-rr
GO:0009799,specification of symmetry,82,-0.454605000994988,-1.78348826053232,0.00444444444444444,0.0496841593780369,0.0408653436311868,BP,mono-sp-vs-rr
GO:0051923,sulfation,11,0.809688686458851,2.00869387234974,0.00444444444444444,0.0496841593780369,0.0408653436311868,BP,mono-sp-vs-rr
GO:0050657,nucleic acid transport,151,-0.35806816249391,-1.52867153682669,0.00446428571428571,0.0496841593780369,0.0408653436311868,BP,mono-sp-vs-rr
GO:0050658,RNA transport,151,-0.35806816249391,-1.52867153682669,0.00446428571428571,0.0496841593780369,0.0408653436311868,BP,mono-sp-vs-rr
GO:0001709,cell fate determination,24,-0.571956041461184,-1.70264016127893,0.0045045045045045,0.0500183441359912,0.0411402114188492,BP,mono-sp-vs-rr
GO:0007368,determination of left/right symmetry,77,-0.473232706544877,-1.8304170781971,0.00452488687782805,0.0500183441359912,0.0411402114188492,BP,mono-sp-vs-rr
GO:0051236,establishment of RNA localization,154,-0.355058867958203,-1.51381904812925,0.00452488687782805,0.0500183441359912,0.0411402114188492,BP,mono-sp-vs-rr
GO:0070989,oxidative demethylation,13,-0.728074201058641,-1.87087048870335,0.00458715596330275,0.0505927223997526,0.0416126389574596,BP,mono-sp-vs-rr
GO:0006403,RNA localization,184,-0.353641751719169,-1.53405211466819,0.00469483568075117,0.0516642455630645,0.0424939694021259,BP,mono-sp-vs-rr
hsa05168,Herpes simplex infection,166,0.382537066923641,1.59861976694925,0.00334448160535117,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa04650,Natural killer cell mediated cytotoxicity,98,0.417488791938266,1.65900519264596,0.00336700336700337,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa05323,Rheumatoid arthritis,79,0.498005284273402,1.89990698454021,0.00336700336700337,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa05152,Tuberculosis,153,0.418984696593327,1.74873980019712,0.00338983050847458,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa05010,Alzheimer's disease,147,0.410325003967796,1.70979882025571,0.00346020761245675,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa04145,Phagosome,136,0.469023721582253,1.92058337309549,0.00347222222222222,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa05203,Viral carcinogenesis,188,0.434400940563802,1.8544779981371,0.00347222222222222,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa05140,Leishmaniasis,69,0.473207315497126,1.76239065235533,0.0034965034965035,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa05016,Huntington's disease,166,0.402687095572467,1.68771198129096,0.00354609929078014,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa05034,Alcoholism,132,0.420073358621925,1.71604095158657,0.003584229390681,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa05162,Measles,116,0.425451708886883,1.70014961434227,0.003584229390681,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa05144,Malaria,37,0.675725123878686,2.22040836672769,0.00359712230215827,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa05131,Shigellosis,62,0.453564983743434,1.63576700448904,0.0036101083032491,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa00190,Oxidative phosphorylation,110,0.495609850745084,1.97065207103203,0.00363636363636364,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa03050,Proteasome,43,0.683820224898525,2.33820617547578,0.00363636363636364,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa04810,Regulation of actin cytoskeleton,166,0.351359011700456,1.47589658383427,0.00363636363636364,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa04062,Chemokine signaling pathway,156,0.386792626271947,1.6148575503888,0.00364963503649635,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa04670,Leukocyte transendothelial migration,93,0.451127486166802,1.73680557100491,0.00367647058823529,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa04060,Cytokine-cytokine receptor interaction,186,0.390615047128688,1.66530353582072,0.003690036900369,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa04966,Collecting duct acid secretion,22,0.644279102828279,1.88310739103041,0.00371747211895911,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa05134,Legionellosis,53,0.596548614240918,2.10376591702557,0.00373134328358209,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa05130,Pathogenic Escherichia coli infection,46,0.569102942149954,1.93735497579951,0.0037593984962406,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa05012,Parkinson's disease,112,0.44861744604466,1.79798220462781,0.00377358490566038,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa05322,Systemic lupus erythematosus,108,0.433565281440033,1.71224837244272,0.00377358490566038,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa05416,Viral myocarditis,55,0.499020142536549,1.75489781495595,0.00380228136882129,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa04610,Complement and coagulation cascades,58,0.446149350764199,1.61399119187304,0.00383141762452107,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
hsa05340,Primary immunodeficiency,33,0.571258933192774,1.8224649459794,0.00396825396825397,0.0414462081128748,0.0331074600080448,KG,mono-sp-vs-rr
DOID:1037,lymphoblastic leukemia,347,0.303585442711136,1.38989345525081,0.00316455696202532,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:1324,lung cancer,463,0.295727683182043,1.38734574435631,0.00328947368421053,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:0050615,respiratory system cancer,471,0.295858038085949,1.38811643501253,0.0033112582781457,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:7148,rheumatoid arthritis,433,0.354334900633398,1.64979196282203,0.00333333333333333,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:409,liver disease,495,0.312562925846067,1.47664344853468,0.00334448160535117,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:0050161,lower respiratory tract disease,369,0.368759454889442,1.7039994362097,0.00335570469798658,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:9351,diabetes mellitus,476,0.293121132854794,1.385168087787,0.00336700336700337,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:936,brain disease,314,0.317547772206293,1.43863182529403,0.00338983050847458,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:10652,Alzheimer's disease,335,0.304832432005329,1.39703833095448,0.00342465753424658,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:4481,allergic rhinitis,68,0.458448553535152,1.72612605675777,0.00342465753424658,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:5419,schizophrenia,468,0.318927618678319,1.52162042951792,0.00342465753424658,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:170,endocrine gland cancer,392,0.297068513754939,1.3840116163448,0.00343642611683849,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:2237,hepatitis,358,0.340060843253075,1.55894136005557,0.00343642611683849,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:2468,psychotic disorder,471,0.319177798965535,1.52242154883283,0.00343642611683849,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:2163,nasal cavity disease,69,0.458433901981508,1.72529178317034,0.00344827586206897,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:2825,nose disease,69,0.458433901981508,1.72529178317034,0.00344827586206897,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:4483,rhinitis,69,0.458433901981508,1.72529178317034,0.00344827586206897,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:680,tauopathy,338,0.302096343445746,1.38386464903181,0.00344827586206897,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:1579,respiratory system disease,410,0.356927047146201,1.65867645223486,0.00346020761245675,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:1936,atherosclerosis,263,0.391694447105164,1.74177800065227,0.00346020761245675,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:374,nutrition disease,238,0.324322352419842,1.43439152939514,0.00347222222222222,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:628,combined T cell and B cell immunodeficiency,39,0.55895415920985,1.86028798269426,0.00347222222222222,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:850,lung disease,361,0.360530244590522,1.65805313368675,0.00347222222222222,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:1612,breast cancer,419,0.306974839499589,1.42677662802635,0.00348432055749129,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:1793,pancreatic cancer,245,0.333149741359217,1.47888008979891,0.00348432055749129,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:18,urinary system disease,345,0.332712363883053,1.51764559701758,0.00348432055749129,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:5093,thoracic cancer,419,0.306974839499589,1.42677662802635,0.00348432055749129,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:2348,arteriosclerotic cardiovascular disease,264,0.387931798402572,1.72648475513946,0.0034965034965035,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:2377,multiple sclerosis,134,0.428562995184019,1.78605643923659,0.0034965034965035,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:2349,arteriosclerosis,272,0.38723365333373,1.73022335934352,0.00350877192982456,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:28,endocrine system disease,278,0.363094431376398,1.64761709144595,0.00350877192982456,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:417,hypersensitivity reaction type II disease,458,0.330045949284754,1.56682940208144,0.00350877192982456,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:865,vasculitis,99,0.511194604370709,2.00003827416581,0.00352112676056338,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:9352,type 2 diabetes mellitus,154,0.392789545755908,1.67242149170347,0.00352112676056338,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:1107,esophageal carcinoma,94,0.39215173218647,1.53934476998173,0.00353356890459364,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:3213,demyelinating disease,137,0.430988126345531,1.79906998351472,0.00353356890459364,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:37,skin disease,250,0.381387109638696,1.7017895286894,0.00353356890459364,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:0070004,myeloma,262,0.356846241229886,1.59268417918718,0.00355871886120996,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:2320,obstructive lung disease,223,0.40515786304974,1.79253327780113,0.00355871886120996,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:557,kidney disease,335,0.34521811499464,1.5624279847403,0.00355871886120996,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:2723,dermatitis,133,0.447941056263064,1.8369154788517,0.003584229390681,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:4905,pancreatic carcinoma,184,0.34371877811913,1.47517547585335,0.003584229390681,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:612,primary immunodeficiency disease,164,0.399344639000024,1.66538380628775,0.003584229390681,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:3454,brain infarction,43,0.493588324707591,1.71341606485151,0.00359712230215827,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:16,integumentary system disease,286,0.350455646453098,1.57685728093859,0.0036101083032491,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:5041,esophageal cancer,111,0.382314088410819,1.54788870176437,0.0036101083032491,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:74,hematopoietic system disease,377,0.356585459972231,1.645425695932,0.0036101083032491,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:0050338,primary bacterial infectious disease,193,0.438716216971715,1.89521789026888,0.0036231884057971,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:4960,bone marrow cancer,267,0.352594158091183,1.57620551216069,0.0036231884057971,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:4971,myelofibrosis,37,0.557630044489083,1.8377404101948,0.0036231884057971,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:1091,tooth disease,110,0.468871925207401,1.89208721565421,0.00364963503649635,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:3905,lung carcinoma,398,0.296938191563778,1.36205221308862,0.00366300366300366,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:1398,parasitic infectious disease,120,0.423084643530282,1.67951220864646,0.00367647058823529,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:1588,thrombocytopenia,57,0.514292409566424,1.83457001747747,0.00367647058823529,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:11077,brucellosis,38,0.565449491078756,1.85811737501834,0.003690036900369,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:12365,malaria,86,0.469153185105982,1.78696777118708,0.003690036900369,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:3083,chronic obstructive pulmonary disease,166,0.406254068374906,1.72869431301343,0.003690036900369,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:3310,atopic dermatitis,102,0.438584908560787,1.71088050743287,0.003690036900369,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:381,arthropathy,70,0.455742573728719,1.71271634567459,0.003690036900369,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:104,bacterial infectious disease,221,0.434637589195475,1.9008890163405,0.0037037037037037,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:2355,anemia,197,0.366321121660235,1.57108928844422,0.0037037037037037,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:2841,asthma,93,0.418188119712533,1.62480746548348,0.0037037037037037,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:3498,pancreatic ductal adenocarcinoma,81,0.414743239009178,1.60560474630645,0.0037037037037037,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:403,mouth disease,131,0.451285265103299,1.86728518371263,0.0037037037037037,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:0080005,bone remodeling disease,98,0.400615193119716,1.61037162710771,0.00371747211895911,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:1123,spondyloarthropathy,57,0.494223587888628,1.78574747488534,0.00371747211895911,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:1883,hepatitis C,198,0.364357503333071,1.58035437498535,0.00371747211895911,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:1712,aortic valve stenosis,15,0.717098224206095,1.87756904255726,0.00373134328358209,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:13241,Behcet's disease,69,0.537494060223202,1.98454932105282,0.00374531835205993,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:715,T-cell leukemia,53,0.540100308805198,1.86772391850306,0.00374531835205993,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:824,periodontitis,87,0.473143586577085,1.85371364112967,0.00374531835205993,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:974,upper respiratory tract disease,88,0.406914036012214,1.56224702022387,0.00374531835205993,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:3388,periodontal disease,100,0.471415003604326,1.86788735580688,0.0037593984962406,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:10952,nephritis,116,0.445364397667898,1.76816518269459,0.00377358490566038,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:399,tuberculosis,123,0.479353720687858,1.93609066259814,0.00377358490566038,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:5082,liver cirrhosis,169,0.368762563752787,1.5780409161611,0.00377358490566038,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:8857,lupus erythematosus,68,0.480712388210511,1.82899055807113,0.00377358490566038,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:1074,kidney failure,111,0.41728926205846,1.67057103232816,0.00378787878787879,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:1602,lymphadenitis,46,0.579538454483532,1.9996547068578,0.00378787878787879,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:2789,parasitic protozoa infectious disease,102,0.460015794973607,1.77890994338871,0.00378787878787879,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:62,aortic valve disease,19,0.661484174169929,1.83555040397504,0.00378787878787879,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:811,lipodystrophy,28,0.641263286731989,2.00672536884133,0.00378787878787879,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:9942,lymph node disease,46,0.579538454483532,1.9996547068578,0.00378787878787879,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:0050589,inflammatory bowel disease,61,0.509709758503508,1.84512249395157,0.00380228136882129,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:3480,uveal disease,36,0.560412044385,1.84713088120851,0.00380228136882129,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:526,Human immunodeficiency virus infectious disease,144,0.444471685048201,1.85953424327744,0.00380228136882129,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:10747,lymphoid leukemia,60,0.507659451786266,1.79323273381945,0.00381679389312977,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:26,pancreas disease,119,0.477920108678936,1.95137288947936,0.00383141762452107,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:9074,systemic lupus erythematosus,65,0.469305185481747,1.75072812866703,0.00384615384615385,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:1176,bronchial disease,106,0.443551686041256,1.73915916432041,0.00386100386100386,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:1247,blood coagulation disease,143,0.417531268218744,1.71482311272705,0.00386100386100386,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:14069,cerebral malaria,18,0.669431381884422,1.86333119013208,0.00386100386100386,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:2213,hemorrhagic disease,126,0.414322909412268,1.67278005486335,0.00386100386100386,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:2218,blood platelet disease,80,0.452505126845478,1.71089607904875,0.00386100386100386,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:13378,Kawasaki disease,42,0.561229804899677,1.88409119069075,0.00390625,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:5295,intestinal disease,98,0.492045453527506,1.93096461326069,0.00390625,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:583,hemolytic anemia,46,0.569298499359686,1.95723940013995,0.00390625,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:720,normocytic anemia,46,0.569298499359686,1.95723940013995,0.00390625,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:13141,uveitis,24,0.583638278186668,1.79009557634269,0.00392156862745098,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:2916,hypersensitivity reaction type IV disease,68,0.470131855589936,1.71644622759284,0.00392156862745098,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:6364,migraine,45,0.576068043478016,1.99597346123535,0.00392156862745098,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:0060180,colitis,46,0.523470613050724,1.78609281697287,0.00395256916996047,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:4989,pancreatitis,84,0.531833620806049,2.02911984115929,0.00395256916996047,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:8577,ulcerative colitis,46,0.523470613050724,1.78609281697287,0.00395256916996047,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:0060031,autoimmune disease of gastrointestinal tract,86,0.426198564739169,1.63458053510291,0.00403225806451613,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:576,proteinuria,50,0.498279207509725,1.69979013389326,0.00403225806451613,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:783,end stage renal failure,27,0.55892685716415,1.75583727781004,0.00404858299595142,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:200,giant cell tumor,15,0.657428982228467,1.72671022274576,0.0040650406504065,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:11729,Lyme disease,14,0.700541978910351,1.83389726500895,0.00408163265306122,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:10608,celiac disease,71,0.426974915579743,1.55894738073525,0.00413223140495868,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:986,alopecia areata,23,0.647045791754082,1.90603478995334,0.004149377593361,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:76,stomach disease,53,0.449154840597144,1.59998648582748,0.00418410041841004,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:784,chronic kidney failure,49,0.529470050181938,1.86650652341773,0.00418410041841004,0.026733809753027,0.0185526949153533,DO,mono-sp-vs-rr
DOID:4029,gastritis,45,0.470155099327434,1.64320571938325,0.00429184549356223,0.0271816881258941,0.0188635129726281,DO,mono-sp-vs-rr
DOID:9970,obesity,222,0.335638086441621,1.47976859602229,0.0068259385665529,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:114,heart disease,357,0.30145912528445,1.38526204997631,0.00687285223367698,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:10155,intestinal cancer,250,0.319848101727288,1.42761029537917,0.00689655172413793,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:5672,large intestine cancer,242,0.323682514447209,1.44095984566884,0.00689655172413793,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:654,overnutrition,228,0.333692476856022,1.47093514337309,0.0069204152249135,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:10763,hypertension,405,0.28783470291367,1.33339436405361,0.00694444444444444,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:627,severe combined immunodeficiency,38,0.535133415796915,1.77375993390427,0.00694444444444444,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:0060100,musculoskeletal system cancer,354,0.30250354649992,1.39280464682099,0.00699300699300699,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:9256,colorectal cancer,241,0.323704733462511,1.43353234136988,0.00706713780918728,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:219,colon cancer,238,0.325311033465743,1.43907633618508,0.00709219858156028,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:3393,coronary artery disease,245,0.343664635609789,1.51451814805792,0.00716845878136201,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:4195,hyperglycemia,106,0.389793137486732,1.57397448656832,0.00716845878136201,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:5844,myocardial infarction,197,0.348664992323461,1.49049307481436,0.0072463768115942,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:201,connective tissue cancer,300,0.310756531662146,1.40133706170371,0.00738007380073801,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:9538,multiple myeloma,217,0.332298635012759,1.4525435141306,0.00738007380073801,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:0050737,autosomal recessive disease,257,0.308852456077549,1.38024198210296,0.00749063670411985,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:3082,interstitial lung disease,121,0.372711355355226,1.50430803934973,0.00749063670411985,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:6590,spondylitis,50,0.485580332414845,1.70137891247973,0.00749063670411985,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:7147,ankylosing spondylitis,50,0.485580332414845,1.70137891247973,0.00749063670411985,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:1564,fungal infectious disease,62,0.423639073634236,1.57696545609039,0.0075187969924812,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:1485,cystic fibrosis,107,0.389119174635215,1.55268737884453,0.00754716981132075,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:326,ischemia,163,0.347853235431515,1.46601801922091,0.00754716981132075,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:10825,essential hypertension,79,0.383031852053931,1.45619671945928,0.00757575757575758,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:75,lymphatic system disease,82,0.458004874439563,1.72238852001649,0.00757575757575758,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:2921,glomerulonephritis,57,0.485773606457874,1.72405950253762,0.00769230769230769,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:0060085,organ system benign neoplasm,186,0.323975502597542,1.39714371987208,0.00772200772200772,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:11714,gestational diabetes,43,0.539603652613005,1.81092237755142,0.00772200772200772,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:10591,pre-eclampsia,194,0.373230954792303,1.58337066710373,0.00775193798449612,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:2214,inherited blood coagulation disease,14,0.724205666939346,1.93436847180664,0.00775193798449612,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:8778,Crohn's disease,34,0.559409021332979,1.79311055445656,0.00775193798449612,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:11335,sarcoidosis,64,0.441203282953111,1.60486348095015,0.00778210116731518,0.0387494968469073,0.0268913259937715,DO,mono-sp-vs-rr
DOID:14221,metabolic syndrome X,17,0.589853176318967,1.61586262816535,0.00796812749003984,0.0391359731143453,0.0271595322968777,DO,mono-sp-vs-rr
DOID:2228,thrombocytosis,29,0.547749350319662,1.71893554795355,0.00796812749003984,0.0391359731143453,0.0271595322968777,DO,mono-sp-vs-rr
DOID:4248,coronary stenosis,13,0.76034090789654,1.89943544419573,0.00806451612903226,0.0393417611159547,0.0273023447896113,DO,mono-sp-vs-rr
DOID:1555,urticaria,35,0.585851507152405,1.92527730152072,0.00816326530612245,0.0395562251746336,0.0274511782812737,DO,mono-sp-vs-rr
DOID:4676,uremia,14,0.69132995353517,1.74303066577728,0.00881057268722467,0.0424082232011747,0.0294304042043435,DO,mono-sp-vs-rr
DOID:3952,adrenal cortex disease,28,0.519430756887344,1.59167626314504,0.010752688172043,0.0512589928057554,0.0355726499133104,DO,mono-sp-vs-rr
DOID:3459,breast carcinoma,312,0.28995577558604,1.31412566013165,0.0107913669064748,0.0512589928057554,0.0355726499133104,DO,mono-sp-vs-rr
DOID:8469,influenza,93,0.384480494625799,1.49229938119887,0.0109489051094891,0.0516673822813797,0.0358560635164554,DO,mono-sp-vs-rr
DOID:2043,hepatitis B,163,0.324102962423281,1.36932393937994,0.0111111111111111,0.0520610503545247,0.0361292607796381,DO,mono-sp-vs-rr
DOID:5223,infertility,142,0.355063847946961,1.46201028595975,0.0112781954887218,0.0520610503545247,0.0361292607796381,DO,mono-sp-vs-rr
DOID:1686,glaucoma,81,0.404099014678451,1.52392901307416,0.0113207547169811,0.0520610503545247,0.0361292607796381,DO,mono-sp-vs-rr
DOID:6713,cerebrovascular disease,81,0.431824214845896,1.65465231413918,0.0113207547169811,0.0520610503545247,0.0361292607796381,DO,mono-sp-vs-rr
DOID:0060058,lymphoma,64,0.437138953125082,1.60807399489458,0.0114503816793893,0.0523238960286018,0.0363116700825404,DO,mono-sp-vs-rr
DOID:12554,hemolytic-uremic syndrome,17,0.606948888809729,1.64724115935951,0.0115384615384615,0.0523947750362845,0.0363608586051486,DO,mono-sp-vs-rr
DOID:10603,glucose intolerance,37,0.503622919262274,1.66609988875869,0.0116279069767442,0.0524709302325581,0.0364137086903305,DO,mono-sp-vs-rr
DOID:1532,pleural disease,18,0.580225249614545,1.60660208899473,0.0118110236220472,0.0529662053112926,0.0367574190525956,DO,mono-sp-vs-rr
DOID:9588,encephalitis,45,0.48036759122974,1.64553138615327,0.0119047619047619,0.0530570252792475,0.0368204461771713,DO,mono-sp-vs-rr
DOID:3978,extrinsic cardiomyopathy,23,0.595595616780625,1.76899553077655,0.0120967741935484,0.0531468531468531,0.0368827848052225,DO,mono-sp-vs-rr
DOID:820,myocarditis,23,0.595595616780625,1.76899553077655,0.0120967741935484,0.0531468531468531,0.0368827848052225,DO,mono-sp-vs-rr
DOID:12894,Sjogren's syndrome,61,0.425595756383256,1.58024090819257,0.0121457489878543,0.0531468531468531,0.0368827848052225,DO,mono-sp-vs-rr
DOID:4851,pilocytic astrocytoma,11,-0.692406623591342,-1.68690464942389,0.012396694214876,0.0539181519466295,0.0374180497544768,DO,mono-sp-vs-rr
DOID:15,reproductive system disease,258,0.301735754450906,1.35003897087607,0.0134680134680135,0.058226980382669,0.0404082849717895,DO,mono-sp-vs-rr
DOID:3324,mood disorder,134,0.333086070158464,1.37339818868876,0.0141342756183746,0.060743732121824,0.0421548571074329,DO,mono-sp-vs-rr
DOID:3770,pulmonary fibrosis,90,0.394016322870784,1.52330047443242,0.0143884892086331,0.0614703503469414,0.0426591146889402,DO,mono-sp-vs-rr
DOID:633,myositis,68,0.391417457749193,1.46347419955233,0.0151515151515152,0.0638429569369529,0.0443056531593375,DO,mono-sp-vs-rr
DOID:10871,age related macular degeneration,55,0.423988435704661,1.46931333421063,0.0152091254752852,0.0638429569369529,0.0443056531593375,DO,mono-sp-vs-rr
DOID:2007,degeneration of macula and posterior pole,55,0.423988435704661,1.46931333421063,0.0152091254752852,0.0638429569369529,0.0443056531593375,DO,mono-sp-vs-rr
DOID:4914,esophagus adenocarcinoma,18,0.569100287683759,1.59413824012779,0.0155642023346304,0.0647170868347339,0.0449122807017544,DO,mono-sp-vs-rr
DOID:50,thyroid gland disease,128,0.353635468157139,1.44505367070551,0.015625,0.0647170868347339,0.0449122807017544,DO,mono-sp-vs-rr
DOID:854,collagen disease,157,0.322190925919867,1.34960724467172,0.0156862745098039,0.0647170868347339,0.0449122807017544,DO,mono-sp-vs-rr
DOID:452,pleomorphic adenoma,16,0.594259437810903,1.63508862560187,0.0159362549800797,0.0653748641796451,0.0453687641777388,DO,mono-sp-vs-rr
DOID:866,vein disease,34,0.514585234882428,1.68020933177713,0.0161943319838057,0.0658533804583286,0.0457008442894947,DO,mono-sp-vs-rr
DOID:0050851,glomerulosclerosis,18,0.607781142596734,1.63991609142492,0.0163265306122449,0.0658533804583286,0.0457008442894947,DO,mono-sp-vs-rr
DOID:1312,focal segmental glomerulosclerosis,18,0.607781142596734,1.63991609142492,0.0163265306122449,0.0658533804583286,0.0457008442894947,DO,mono-sp-vs-rr
DOID:3856,male reproductive organ cancer,340,0.273260214618425,1.25759585546588,0.0168350168350168,0.0675271230826786,0.0468623860436726,DO,mono-sp-vs-rr
DOID:3947,adrenal gland hyperfunction,17,0.603479422695189,1.65690896131057,0.0177935943060498,0.070839874411303,0.0491613649508386,DO,mono-sp-vs-rr
DOID:3908,non-small cell lung carcinoma,334,0.293054827599436,1.32686761523808,0.0178571428571429,0.070839874411303,0.0491613649508386,DO,mono-sp-vs-rr
DOID:8618,oral cavity cancer,47,0.438294223645592,1.5007477862973,0.0179856115107914,0.0709596257420293,0.0492444698253477,DO,mono-sp-vs-rr
DOID:9553,adrenal gland disease,29,0.511795482692129,1.57662709708266,0.0181818181818182,0.0713438735177866,0.0495111296026628,DO,mono-sp-vs-rr
DOID:4606,bile duct cancer,101,0.373569263825727,1.46905572693401,0.0183823529411765,0.0713551549652119,0.0495189586870402,DO,mono-sp-vs-rr
DOID:4897,bile duct carcinoma,101,0.373569263825727,1.46905572693401,0.0183823529411765,0.0713551549652119,0.0495189586870402,DO,mono-sp-vs-rr
DOID:4928,intrahepatic cholangiocarcinoma,22,0.560339925074348,1.60933088449832,0.0186567164179104,0.0719180811220018,0.0499096174574615,DO,mono-sp-vs-rr
DOID:6000,congestive heart failure,149,0.335942377784631,1.41135413586184,0.0187265917602996,0.0719180811220018,0.0499096174574615,DO,mono-sp-vs-rr
